Study design
Cancer
CANCER
This prospective, randomized, controlled trial conformed to the ethical guidelines of the 1975 Declaration of Helsinki and was approved by the Ethics Committee of Zhejiang Cancer Hospital ([2015]-01–13), and the study was registered before patient enrollment at clinicaltrials.gov with registration No. NCT02923128. Written informed consent was obtained from all patients prior to the study.